These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22627902)

  • 21. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.
    Kassanjee R; McWalter TA; Welte A
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):45-9. PubMed ID: 24090052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating HIV incidence based on combined prevalence testing.
    Balasubramanian R; Lagakos SW
    Biometrics; 2010 Mar; 66(1):1-10. PubMed ID: 19397583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.
    Balzer L; Staples P; Onnela JP; DeGruttola V
    Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis.
    Sempa JB; Grebe E; Welte A
    PLoS One; 2022; 17(7):e0271763. PubMed ID: 35901053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eight interval estimators of a common rate ratio under stratified Poisson sampling.
    Lui KJ
    Stat Med; 2004 Apr; 23(8):1283-96. PubMed ID: 15083483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.
    Mahiane GS; Ouifki R; Brand H; Delva W; Welte A
    PLoS One; 2012; 7(9):e44377. PubMed ID: 22984497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV incidence estimation among female sex workers in South Africa: a multiple methods analysis of cross-sectional survey data.
    Kassanjee R; Welte A; Otwombe K; Jaffer M; Milovanovic M; Hlongwane K; Puren AJ; Hill N; Mbowane V; Dunkle K; Gray G; Abdullah F; Jewkes R; Coetzee J
    Lancet HIV; 2022 Nov; 9(11):e781-e790. PubMed ID: 36075252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
    Grebe E; Welte A; Johnson LF; van Cutsem G; Puren A; Ellman T; Etard JF; ; Huerga H
    PLoS One; 2018; 13(9):e0203638. PubMed ID: 30212513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimators of the local false discovery rate designed for small numbers of tests.
    Padilla M; Bickel DR
    Stat Appl Genet Mol Biol; 2012 Oct; 11(5):4. PubMed ID: 23079518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.
    Molebatsi K; Gabaitiri L; Mokgatlhe L; Moyo S; Gaseitsiwe S; Wirth KE; DeGruttola V; Tchetgen Tchetgen E
    Stat Med; 2020 Oct; 39(24):3255-3271. PubMed ID: 32875624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A more reliable species richness estimator based on the Gamma-Poisson model.
    Chiu CH
    PeerJ; 2023; 11():e14540. PubMed ID: 36632143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should biomarker estimates of HIV incidence be adjusted?
    Brookmeyer R
    AIDS; 2009 Feb; 23(4):485-91. PubMed ID: 19165087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.
    Romero-Severson EO; Lee Petrie C; Ionides E; Albert J; Leitner T
    Int J Epidemiol; 2015 Jun; 44(3):998-1006. PubMed ID: 26163684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating Disease Duration in Cross-sectional Surveys.
    Schmidt WP; Boisson S; Kenward MG
    Epidemiology; 2015 Nov; 26(6):839-45. PubMed ID: 26247488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How should we best estimate the mean recency duration for the BED method?
    Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
    PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bootstrap confidence intervals and bias correction in the estimation of HIV incidence from surveillance data with testing for recent infection.
    Carnegie NB
    Stat Med; 2011 Apr; 30(8):854-65. PubMed ID: 21432879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
    Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
    PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the statistical accuracy of biomarker assays for HIV incidence.
    Brookmeyer R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):406-14. PubMed ID: 20436353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.